ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia
(2024) In Annals of Oncology 35(1). p.15-28
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/40d59a81-720d-4fed-a489-dfe99cb951ae
- author
- Hoelzer, D. ; Bassan, R. ; Boissel, N. ; Roddie, C. ; Ribera, J. M. and Jerkeman, M. LU
- author collaboration
- organization
- publishing date
- 2024-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- acute lymphoblastic leukaemia, ESMO Clinical Practice Guideline update, immunotherapy, treatment, tyrosine kinase inhibitor
- in
- Annals of Oncology
- volume
- 35
- issue
- 1
- pages
- 14 pages
- publisher
- Oxford University Press
- external identifiers
-
- scopus:85180598764
- pmid:37832649
- ISSN
- 0923-7534
- DOI
- 10.1016/j.annonc.2023.09.3112
- language
- English
- LU publication?
- yes
- id
- 40d59a81-720d-4fed-a489-dfe99cb951ae
- date added to LUP
- 2024-02-07 15:38:45
- date last changed
- 2024-07-31 07:56:34
@article{40d59a81-720d-4fed-a489-dfe99cb951ae, author = {{Hoelzer, D. and Bassan, R. and Boissel, N. and Roddie, C. and Ribera, J. M. and Jerkeman, M.}}, issn = {{0923-7534}}, keywords = {{acute lymphoblastic leukaemia; ESMO Clinical Practice Guideline update; immunotherapy; treatment; tyrosine kinase inhibitor}}, language = {{eng}}, number = {{1}}, pages = {{15--28}}, publisher = {{Oxford University Press}}, series = {{Annals of Oncology}}, title = {{ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia}}, url = {{http://dx.doi.org/10.1016/j.annonc.2023.09.3112}}, doi = {{10.1016/j.annonc.2023.09.3112}}, volume = {{35}}, year = {{2024}}, }